Erratum: Managing myelofibrosis (MF) that "blasts" through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118)

R. M. Scherber; R. A. Mesa

doi:10.1182/hematology.201900100

Erratum: Managing myelofibrosis (MF) that "blasts" through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118)

R. M. Scherber, R. A. Mesa

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

Page 118: The author affiliations are incorrect. The author and affiliation lines should read as shown below. The error has been corrected in the online version. Robyn M. Scherber and Ruben A. Mesa UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX.

Original language	English (US)
Pages (from-to)	630
Number of pages	1
Journal	Hematology (United States)
Volume	2019
Issue number	1
DOIs	https://doi.org/10.1182/hematology.201900100
State	Published - Dec 6 2019
Externally published	Yes

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/hematology.201900100

Fingerprint

Dive into the research topics of 'Erratum: Managing myelofibrosis (MF) that "blasts" through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118)'. Together they form a unique fingerprint.

Cite this

Erratum: Managing myelofibrosis (MF) that "blasts" through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118). / Scherber, R. M.; Mesa, R. A.
In: Hematology (United States), Vol. 2019, No. 1, 06.12.2019, p. 630.

Research output: Contribution to journal › Comment/debate › peer-review

@article{71cbdc10d9f84e6082eadfd25fe94ad3,

title = "Erratum: Managing myelofibrosis (MF) that {"}blasts{"} through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118)",

abstract = "Page 118: The author affiliations are incorrect. The author and affiliation lines should read as shown below. The error has been corrected in the online version. Robyn M. Scherber and Ruben A. Mesa UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX.",

author = "Scherber, {R. M.} and Mesa, {R. A.}",

year = "2019",

month = dec,

day = "6",

doi = "10.1182/hematology.201900100",

language = "English (US)",

volume = "2019",

pages = "630",

journal = "Hematology (United States)",

issn = "1520-4391",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Managing myelofibrosis (MF) that "blasts" through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118)

AU - Scherber, R. M.

AU - Mesa, R. A.

PY - 2019/12/6

Y1 - 2019/12/6

N2 - Page 118: The author affiliations are incorrect. The author and affiliation lines should read as shown below. The error has been corrected in the online version. Robyn M. Scherber and Ruben A. Mesa UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX.

AB - Page 118: The author affiliations are incorrect. The author and affiliation lines should read as shown below. The error has been corrected in the online version. Robyn M. Scherber and Ruben A. Mesa UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX.

UR - http://www.scopus.com/inward/record.url?scp=85076484978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076484978&partnerID=8YFLogxK

U2 - 10.1182/hematology.201900100

DO - 10.1182/hematology.201900100

M3 - Comment/debate

C2 - 31808826

AN - SCOPUS:85076484978

SN - 1520-4391

VL - 2019

SP - 630

JO - Hematology (United States)

JF - Hematology (United States)

IS - 1

ER -

Erratum: Managing myelofibrosis (MF) that "blasts" through: Advancements in the treatment of relapsed/refractory and blast-phase MF (Hematology (United States) (2018) 2018 (118-126) DOI: 10.1182/asheducation-2018.1.118)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this